Skip to main content

Peer Review reports

From: PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

Original Submission
2 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Aug 2012 Reviewed Reviewer Report - William Schelman
4 Sep 2012 Reviewed Reviewer Report - James Cleary
4 Sep 2012 Reviewed Reviewer Report - Wan-Teck Lim
3 Oct 2012 Author responded Author comments - Mark McKeage
Resubmission - Version 3
3 Oct 2012 Submitted Manuscript version 3
18 Oct 2012 Author responded Author comments - Mark McKeage
Resubmission - Version 4
18 Oct 2012 Submitted Manuscript version 4
Publishing
23 Oct 2012 Editorially accepted
25 Oct 2012 Article published 10.1186/1471-2407-12-496

You can find further information about peer review here.

Back to article page